Lack of clinical efficacy of additional factor XIII treatment in patients with steroid refractory colitis

Zeitschrift fur Gastroenterologie

Volumn 37, Issue 10, 1999, Pages 999-1004

  Bregenzer, N ^a   Caesar, I ^a   Andus, T ^a   Hamling J ^b   Malchow, H ^c   Schreiber, S ^d   Scholmerich J ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Tabea Hospital Hamburg   (Germany)

^c City Hospital   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Steroid refractory; Ulcerative colitis 1 factor XIII

Indexed keywords

BLOOD CLOTTING FACTOR 13 CONCENTRATE; PLACEBO; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESISTANCE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; RANDOMIZED CONTROLLED TRIAL; REACTIVE ARTHRITIS; STEROID THERAPY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; DOUBLE-BLIND METHOD; FACTOR XIII; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREDNISOLONE; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 0032845363     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. McDonagh J, Colman RW, Hirsh J, Marder VJ, Salzman EW (eds.). Structure and function of factor XIII. In: Hemostasis and thrombosis: Basic principles and clinical practice. Philadelphia, J. B. Lippincott Company, 1987, pp 289-300
2. Duckert F. The fibrin stabilization factors: Factor XIII. Blut 1973; 26: 177-9
3. Chiarantini E, Valanzano R, Liotta AA et al. Hemostatic abnormalities in inflammatory bowel disease. Thromb-Res 1996; 82: 137-46
4. Wisen O, Garlund B. Hemostasis in Crohn's disease: Low FXIII levels in active disease. Scand J Gastroenterol 1988; 23: 961-6
5. Lorenz R, Olbert P, Born P. Factor XIII in chronic inflammatory bowel disease. Semin Thromb Hemost 1996; 22: 451-5
6. Dempfle CE, Magez J, Röckel A et al. Aquired factor XIII-deficiency and substitution of factor XIII in exacerbated ulcerative colitis and Crohn's disease. In: McDonagh JR, Seitz R, Egbring R (eds.), Factor XIII, 2nd. Int. Conf. Stuttgart, New York. Schattauer, 1993, pp 181-92
7. Van-Bodegraven AA, Tuynman HA, Schoorl M, Kruishoop AM, Bartels PC. Fibrinolytic split products, fibrinolysis, and factor XIII in inflammatory bowel disease. Scand J Gastroenterol 1995; 30: 580-5
8. Stadnicki A, Kloczko J, Nowak A, Sierka E, Sliwinski Z. Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis. Am J Gastroenterol 1991; 86: 690-3
9. Tromm A, Hüppe D, Betz A, Koffler A, May B. Factor XIII-activity in inflammatory bowel diseases. Europ J Gastroenterol Hepatol 1991; (suppl. 1) 3: 60 (abstract)
10. Seitz R, Leugner F, Katschinski M et al. Ulcerative colitis and Crohn's disease: Factor XIII, inflammation and haemostasis. Digestion 1994; 55: 361-7
11. Galloway MJ, Mackie MJ, McVerry BA. Reduced levels of factor XIII in patients with chronic inflammatory bowel disease. Clin Lab Haemat 1983; 5: 427-8
12. Suzuki R, Toda H, Takamura Y. Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate. Blood 1989; 59: 162-4
13. Lorenz R, Born P, Glassen M. Factor XIII substitution in ulcerative colitis. Lancet 1995; 345: 449-50
14. Lorenz R, Heinmuller M, Classen M, Tornieporth N, Gain T. Substitution of factor XIII: A therapeutic approach to ulcerative colitis. Haemostasis 1991; 21: 5-9
15. Lorenz R, Olbert P, Born P. Factor XIII in chronic inflammatory bowel diseases. Semin Thromb Hemost 1996; 22: 451-5
16. Lorenz R, Born P, Olbert P, Classen M. Multicentre trials: Factor XIII in ulcerative colitis. Blood Coagul Fibrinolysis 1995; 6: 352-3
17. Rachmilewitz D. Coated mesalazine versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. BMJ 1989; 298: 82-6
18. Baron JH, Connell AM, Kanaghinis TG, Lennard-Jones JE, Avery Jones F. Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisolone. BMJ 1962; 2: 441-3
19. Truelove S, Witts L. Cortison in active ulcerative colitis. File report on a therapeutic trial. BMJ 1955; 2: 1041-8
20. Schölmerich J. Therapie chronisch entzündlicher Darmerkrankungen. Klin Gegenwart 1996; 4: 16-27
21. Kruis W, Malchow H, Behnke M et al. Additive Factor XIII treatment for severe ulcerative colitis. A double blind placebo-controlled trial. Gastroenterol 1998; (suppl.) 114: A1014